Evidence that SARS-CoV-2 Induces Lung-Cell Senescence:Potential Impact on COVID-19 Lung Disease
Lipskaia, L. (Larissa), Maisonnasse, P. (Pauline), Fouillade, C. (Charles), Sencio, V. (Valentin), Pascal, Q. (Quentin), Flaman, J-M. (Jean-Michel), Born, E. (Emmanuelle), London-Vallejo, A. (Arturo), Le Grand, R. (Roger), Bernard, D. (David), Trottein, F. (François), Adnot, S. (Serge)
Abstract
Supported by grants from the ANR AAP Flash COVID19 under reference AM-CoV-Path (RLG), ANR AAP Recherche-Action COVID19 under reference SENOCOVID - ANR 20 COV3 0006, ANR (Lustra), ANR (Influenzaging), the Institut National Du Cancer (INCA), EDF (CT9818), the Fondation pour la Recherche Médicale (FRM), and La Ligue contre le Cancer-Paris (RS21/75-24).
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakLungLung diseaseDiseaseSenescenceMedicineBetacoronavirusSars virusVirologyPathologyInternal medicineInfectious disease (medical specialty)OutbreakMedical and Biological Ozone ResearchTelomeres, Telomerase, and SenescenceLong-Term Effects of COVID-19